Cornerstone Enterprises, LLC Eli Lilly & CO Transaction History

Cornerstone Enterprises, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$727.2 - $932.06 $2.63 Million - $3.37 Million	-3,618 Closed	0 $0
Q3 2024 Feb 13, 2025	BUY	$772.14 - $960.02 $470,233 - $584,652	609 Added 20.24%	3,618 $3.21 Billion
Q2 2024 Feb 13, 2025	BUY	$724.87 - $909.04 $20,296 - $25,453	28 Added 0.94%	3,009 $2.72 Billion
Q1 2024 Feb 13, 2025	BUY	$592.2 - $792.28 $1.77 Million - $2.36 Million	2,981 New	2,981 $2.27 Billion

4,183

752M

8.6M

9.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $828B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Cornerstone Enterprises, LLC, based on Form 13F filings with the SEC.

Stay updated on Cornerstone Enterprises, LLC with notifications on news.